Medicinal Products

ALOSTIL 2%

Generic drug of the therapeutic class: Dermatology
active ingredients: Minoxidil
laboratory: Pfizer Holding France

Solution for cutaneous application
Case of 1 Bottle with sprayer or applicator pad of 60 ml
All forms

Indication

This medicine is indicated in case of moderate hair loss (androgenetic alopecia) of the adult, male or female. It promotes hair growth and stabilizes the phenomenon of falling.

Dosage ALOSTIL 2% Solution for dermal application Case of 1 bottle with sprayer or applicator pad of 60 ml

Cutaneous application.
RESERVED FOR THE ADULT.
- Apply 2 times daily a dose of 1 ml on the scalp taking as a starting point the center of the area to be treated.
- The daily dose should not exceed 2 ml.
- Spread the product with the fingertips so as to cover the entire area to be treated (see application mode depending on the delivery system).
- Before and after applying the solution, wash your hands thoroughly.
- Apply on perfectly dry hair and scalp.
- The method of application varies depending on the delivery system used with the vial.
- Sprayer: this system is suitable for application over large areas.
1-Remove the outer cap of the bottle.
2-Unscrew and remove the inner cap.
3-Insert the sprayer in the bottle, screw it firmly and remove the small transparent cap.
4-For the application: direct the sprayer towards the center of the surface to be treated, press once and spread the product with the fingertips. Repeat the procedure 6 times to apply a dose of 1 ml.
Avoid inhaling the product.
Replace the cap on the vial after use.
- Sprayer with an applicator: This system is suitable for application on small areas or under the hair.
1-Remove the outer cap of the bottle.
2-Unscrew and remove the inner cap.
3-Insert the sprayer in the bottle, screw it firmly and remove the small transparent cap.
4-Pull up firmly to remove the "head" (carrying an arrow) from the sprayer.
5-Insert the applicator onto the sprayer shaft (now without a head) and push it all the way down. Finally remove the cap (transparent plastic) from the end of the applicator.
6-For the application: direct the sprayer towards the center of the surface to be treated or under the hair, squeeze once and spread the product with the fingertips. Repeat the procedure 6 times to apply a dose of 1 ml.
Avoid inhaling the product.
Replace the small transparent cap on the end of the applicator after use.
Applicator pad: This system is suitable for application on small surfaces.
1-Remove the outer cap of the bottle.
2-Unscrew and remove the inner cap.
3-Insert the applicator pad on the bottle and screw firmly.
4-For the application: hold the bottle vertically and press it once to fill the reservoir to the black line: this reservoir then contains a dose of 1 ml.
5-Turn the vial and apply the product with the applicator pad on the surface to be treated, until the 1 ml reservoir is empty.
Replace the outer cap on the vial after use.

Against indications

CONTRAINDICATED:
Hypersensitivity to minoxidil or any of the other ingredients of the solution.
NOT RECOMMENDED :
- Sun exposure is not recommended when applying minoxidil.
- Efficacy and safety in subjects under 18 years of age and over 65 years of age have not been studied.
- Breast-feeding: administered by the general route, minoxidil passes into breast milk; therefore the drug should be avoided in breastfeeding women.

Alostil side effects

- Most often minor skin reactions: local irritation with, in particular, desquamations, erythema, dermatitis, dry skin, hypertrichosis (at a distance), burning sensation and pruritus (especially due to the presence of ethanol).
- More rarely: allergy (sensitivity, rhinitis, rash, generalized erythema, edema of the face), dizziness, tingling, headache, weakness, neuritis, edema, taste alteration; ear infection (especially otitis externa), blurred vision, eye irritation.
- Finally, it has been possible to report some cases of alopecia, irregular hair, chest pain, changes in blood pressure and pulse.
- Liver abnormalities may occur.
- Due to the presence of propylene glycol, risk of contact eczema.
It should be noted, however, that these medical events, particularly those that have been reported most rarely, have not been able to establish formal accountability for treatment.

Popular Posts

Category Medicinal Products, Next Article